Data / Form D filings / AMPHP, INC.
AMPHP, INC.: Form D filings
AMPHP, INC., a biotechnology company in Park City, UT, filed 3 Form D notices with the SEC between 2021 and 2023. The latest, on November 16, 2023, reports $32.1 million sold of a $32.5 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1090 Center Drive, Park City, UT, 84098
- Phone
- (310) 383-4888
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1856578
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 16, 2023 | New notice | $32,499,999 | $32,114,924 | $385,075 | 2 | Nov 1, 2023 | sec.gov |
| May 20, 2022 | New notice | $6,500,000 | $5,675,617 | $824,383 | 28 | May 5, 2022 | sec.gov |
| Apr 14, 2021 | New notice | $1,353,485 | $1,353,485 | 3 | Mar 31, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Peter Rahal | Director | |
| Kevin Datoo | Director | |
| Erica Good | Executive Officer, Director | |
| Jeffrey Byers | Executive Officer, Director |
Other biotechnology companies in Utah that filed recently
- Life Impact Partners 1 LLC offering · Oct 22, 2026
- 3Helix, Inc. $7.8 million · Sep 21, 2026
- Halia Therapeutics, Inc. $3.5 million · Aug 31, 2026
- Paterna BioSciences HoldCo Inc. $6.3 million · Aug 12, 2026
Every Form D from the week of Nov 13, 2023 · All recent filings in Utah · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what AMPHP, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.